ZBIO
ProShares UltraPro Short NASDAQ Biotechnology
ZBIO
ZBIO
Delisted
ZBIO was delisted on the 27th of March, 2020.
3 hedge funds and large institutions have $1.41M invested in ProShares UltraPro Short NASDAQ Biotechnology in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+2
Holders Change %
+200%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
$823K
Puts
$410K
Net Calls
+$413K
Net Calls Change
+$413K
Top Buyers
| 1 |
VF
1
Virtu Financial
New York
|
$1.08M |
| 2 |
2
Jane Street
New York
|
$309K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$16K |
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VF
1
Virtu Financial
New York
| $1.08M | +$674K | +10,279 | +164% |
|
|
2
Jane Street
New York
| $309K | +$309K | +4,705 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $16K | +$16K | +236 | New |
|